Eledon Pharmaceuticals (ELDN) Net Equity Issued and Repurchased (2013 - 2024)
Eledon Pharmaceuticals' (ELDN) quarterly Net Equity Issued and Repurchased came in at $4.0 million in Q3 2024, down 55.01% on a QoQ basis from $8.9 million in Q4 2020.
Analysis
Eledon Pharmaceuticals (ELDN) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends
Eledon Pharmaceuticals (ELDN) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $4.0 million in Q3 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $4.0 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $4.0 million (changed N/A YoY) and the FY2020 annual result came in at $9.0 million, down 6.99% from the prior year.
- Net Equity Issued and Repurchased retreated to $4.0 million in Q3 2024, from $8.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.9 million in Q4 2020 to a low of $110000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Eledon Pharmaceuticals | 344.87 Mn | 344.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 4.00 Mn |
| Dec 31, 2020 | 8.89 Mn |
| Mar 31, 2020 | 110,000.00 |
| Jun 30, 2019 | 9.57 Mn |
| Mar 31, 2019 | 107,000.00 |
| Dec 31, 2018 | 1,000.00 |
| Sep 30, 2018 | -1,000.00 |
| Mar 31, 2018 | 7.49 Mn |
| Dec 31, 2017 | 750,000.00 |
| Dec 31, 2013 | 15.49 Mn |